BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shannon-lowe C, Rowe M. Epstein Barr virus entry; kissing and conjugation. Current Opinion in Virology 2014;4:78-84. [DOI: 10.1016/j.coviro.2013.12.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 Houen G, Trier NH. Epstein-Barr Virus and Systemic Autoimmune Diseases. Front Immunol 2020;11:587380. [PMID: 33488588 DOI: 10.3389/fimmu.2020.587380] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
2 Wang M, Jiang S, Han Z, Zhao B, Wang L, Zhou Z, Wang Y. Expression and immunogenic characterization of recombinant gp350 for developing a subunit vaccine against Epstein-Barr virus. Appl Microbiol Biotechnol 2016;100:1221-30. [PMID: 26433969 DOI: 10.1007/s00253-015-7027-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
3 Wallaschek N, Reuter S, Silkenat S, Wolf K, Niklas C, Kayisoglu Ö, Aguilar C, Wiegering A, Germer CT, Kircher S, Rosenwald A, Shannon-Lowe C, Bartfeld S. Ephrin receptor A2, the epithelial receptor for Epstein-Barr virus entry, is not available for efficient infection in human gastric organoids. PLoS Pathog 2021;17:e1009210. [PMID: 33596248 DOI: 10.1371/journal.ppat.1009210] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Nothelfer K, Sansonetti PJ, Phalipon A. Pathogen manipulation of B cells: the best defence is a good offence. Nat Rev Microbiol 2015;13:173-84. [PMID: 25659322 DOI: 10.1038/nrmicro3415] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
5 Hosoi H, Imadome KI, Tamura S, Kuriyama K, Murata S, Yamashita Y, Mushino T, Oiwa T, Kobata H, Nishikawa A, Nakakuma H, Hanaoka N, Isobe Y, Ohshima K, Sonoki T. An Epstein-Barr virus susceptible immature T-cell line, WILL4, established from a patient with T-lymphoblastic lymphoma bearing CD21 and a clonal EBV genome. Leuk Res 2017;55:1-5. [PMID: 28110206 DOI: 10.1016/j.leukres.2017.01.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Lünemann A, Rowe M, Nadal D. Innate Immune Recognition of EBV. Curr Top Microbiol Immunol 2015;391:265-87. [PMID: 26428378 DOI: 10.1007/978-3-319-22834-1_9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
7 Zhang H, Li Y, Wang HB, Zhang A, Chen ML, Fang ZX, Dong XD, Li SB, Du Y, Xiong D, He JY, Li MZ, Liu YM, Zhou AJ, Zhong Q, Zeng YX, Kieff E, Zhang Z, Gewurz BE, Zhao B, Zeng MS. Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry. Nat Microbiol 2018;3:1-8. [PMID: 29292383 DOI: 10.1038/s41564-017-0080-8] [Cited by in Crossref: 58] [Cited by in F6Publishing: 78] [Article Influence: 14.5] [Reference Citation Analysis]
8 Frau J, Coghe G, Lorefice L, Fenu G, Cocco E. Infections and Multiple Sclerosis: From the World to Sardinia, From Sardinia to the World. Front Immunol 2021;12:728677. [PMID: 34691035 DOI: 10.3389/fimmu.2021.728677] [Reference Citation Analysis]
9 Gillet L, Frederico B, Stevenson PG. Host entry by gamma-herpesviruses--lessons from animal viruses? Curr Opin Virol 2015;15:34-40. [PMID: 26246389 DOI: 10.1016/j.coviro.2015.07.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
10 Craig JW, Dorfman DM. Flow Cytometry of T cells and T-cell Neoplasms. Clinics in Laboratory Medicine 2017;37:725-51. [DOI: 10.1016/j.cll.2017.07.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
11 Tiwari D, Jakhmola S, Pathak DK, Kumar R, Jha HC. Temporal In Vitro Raman Spectroscopy for Monitoring Replication Kinetics of Epstein-Barr Virus Infection in Glial Cells. ACS Omega 2020;5:29547-60. [PMID: 33225186 DOI: 10.1021/acsomega.0c04525] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
12 Li N, Zhao L, Zhan X. Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol 2021;236:2959-75. [PMID: 32959892 DOI: 10.1002/jcp.30055] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
13 Okonko IO, Makinde TS, Okonko BJ, Ogbu O. Immunological and epidemiological evaluation of EBV infections among HIV-1 infected individuals in Abakaliki, Nigeria supports the potential use of neutrophils as a marker of EBV in HIV disease progression and as useful markers of immune activation. J Immunoassay Immunochem 2020;41:158-70. [PMID: 31885335 DOI: 10.1080/15321819.2019.1705483] [Reference Citation Analysis]
14 Cui X, Snapper CM. Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases. Front Immunol 2021;12:734471. [PMID: 34691042 DOI: 10.3389/fimmu.2021.734471] [Reference Citation Analysis]
15 Dollery SJ, Santiago-Crespo RJ, Chatterjee D, Berger EA. Glycoprotein K8.1A of Kaposi's Sarcoma-Associated Herpesvirus Is a Critical B Cell Tropism Determinant Independent of Its Heparan Sulfate Binding Activity. J Virol 2019;93:e01876-18. [PMID: 30567992 DOI: 10.1128/JVI.01876-18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
16 Houen G, Trier NH, Frederiksen JL. Epstein-Barr Virus and Multiple Sclerosis. Front Immunol 2020;11:587078. [PMID: 33391262 DOI: 10.3389/fimmu.2020.587078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
17 Sobhy H. A comparative review of viral entry and attachment during large and giant dsDNA virus infections. Arch Virol 2017;162:3567-85. [PMID: 28866775 DOI: 10.1007/s00705-017-3497-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 5.6] [Reference Citation Analysis]
18 Coghill AE, Bu W, Nguyen H, Hsu WL, Yu KJ, Lou PJ, Wang CP, Chen CJ, Hildesheim A, Cohen JI. High Levels of Antibody that Neutralize B-cell Infection of Epstein-Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma. Clin Cancer Res 2016;22:3451-7. [PMID: 26920891 DOI: 10.1158/1078-0432.CCR-15-2299] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
19 Helenius A. Virus Entry: Looking Back and Moving Forward. J Mol Biol 2018;430:1853-62. [PMID: 29709571 DOI: 10.1016/j.jmb.2018.03.034] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 12.3] [Reference Citation Analysis]
20 Chatterjee B, Leung CS, Münz C. Animal models of Epstein Barr virus infection. J Immunol Methods 2014;410:80-7. [PMID: 24815603 DOI: 10.1016/j.jim.2014.04.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
21 Persson Berg L, Thomsson E, Hasi G, Bäckström M, Bergström T. Recombinant Epstein-Barr virus glycoprotein 350 as a serological antigen. J Virol Methods 2020;284:113927. [PMID: 32650039 DOI: 10.1016/j.jviromet.2020.113927] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Preiksaitis JK, Cockfield SM, Peters AC. Epstein–Barr Virus Infection and Lymphoproliferative Disorders After Transplantation. In: Ljungman P, Snydman D, Boeckh M, editors. Transplant Infections. Cham: Springer International Publishing; 2016. pp. 477-512. [DOI: 10.1007/978-3-319-28797-3_26] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Barros MHM, Vera-Lozada G, Segges P, Hassan R, Niedobitek G. Revisiting the Tissue Microenvironment of Infectious Mononucleosis: Identification of EBV Infection in T Cells and Deep Characterization of Immune Profiles. Front Immunol 2019;10:146. [PMID: 30842768 DOI: 10.3389/fimmu.2019.00146] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
24 Cui X, Cao Z, Ishikawa Y, Cui S, Imadome KI, Snapper CM. Immunization with Epstein-Barr Virus Core Fusion Machinery Envelope Proteins Elicit High Titers of Neutralizing Activities and Protect Humanized Mice from Lethal Dose EBV Challenge. Vaccines (Basel) 2021;9:285. [PMID: 33808755 DOI: 10.3390/vaccines9030285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Wu Y, Wei F, Tang L, Liao Q, Wang H, Shi L, Gong Z, Zhang W, Zhou M, Xiang B, Wu X, Li X, Li Y, Li G, Xiong W, Zeng Z, Xiong F, Guo C. Herpesvirus acts with the cytoskeleton and promotes cancer progression. J Cancer 2019;10:2185-93. [PMID: 31258722 DOI: 10.7150/jca.30222] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
26 Myster F, Gong MJ, Javaux J, Suárez NM, Wilkie GS, Connelley T, Vanderplasschen A, Davison AJ, Dewals BG. Alcelaphine herpesvirus 1 genes A7 and A8 regulate viral spread and are essential for malignant catarrhal fever. PLoS Pathog 2020;16:e1008405. [PMID: 32176737 DOI: 10.1371/journal.ppat.1008405] [Reference Citation Analysis]
27 Van Cleemput J, Poelaert KCK, Laval K, Nauwynck HJ. Unravelling the first key steps in equine herpesvirus type 5 (EHV5) pathogenesis using ex vivo and in vitro equine models. Vet Res 2019;50:13. [PMID: 30777128 DOI: 10.1186/s13567-019-0630-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Sausen DG, Bhutta MS, Gallo ES, Dahari H, Borenstein R. Stress-Induced Epstein-Barr Virus Reactivation. Biomolecules 2021;11:1380. [PMID: 34572593 DOI: 10.3390/biom11091380] [Reference Citation Analysis]
29 Hislop AD. Early virological and immunological events in Epstein–Barr virus infection. Current Opinion in Virology 2015;15:75-9. [DOI: 10.1016/j.coviro.2015.08.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
30 Moghoofei M, Mostafaei S, Nesaei A, Etemadi A, Sadri Nahand J, Mirzaei H, Rashidi B, Babaei F, Khodabandehlou N. Epstein-Barr virus and thyroid cancer: The role of viral expressed proteins. J Cell Physiol 2019;234:3790-9. [PMID: 30362517 DOI: 10.1002/jcp.27144] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
31 Cui X, Cao Z, Chen Q, Arjunaraja S, Snow AL, Snapper CM. Rabbits immunized with Epstein-Barr virus gH/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350. Vaccine 2016;34:4050-5. [PMID: 27291087 DOI: 10.1016/j.vaccine.2016.06.021] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
32 Trier N, Izarzugaza J, Chailyan A, Marcatili P, Houen G. Human MHC-II with Shared Epitope Motifs Are Optimal Epstein-Barr Virus Glycoprotein 42 Ligands-Relation to Rheumatoid Arthritis. Int J Mol Sci 2018;19:E317. [PMID: 29361739 DOI: 10.3390/ijms19010317] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
33 Alari-Pahissa E, Ataya M, Moraitis I, Campos-Ruiz M, Altadill M, Muntasell A, Moles A, López-Botet M. NK cells eliminate Epstein-Barr virus bound to B cells through a specific antibody-mediated uptake. PLoS Pathog 2021;17:e1009868. [PMID: 34415956 DOI: 10.1371/journal.ppat.1009868] [Reference Citation Analysis]
34 Sinclair AJ, Moalwi MH, Amoaten T. Is EBV Associated with Breast Cancer in Specific Geographic Locations? Cancers (Basel) 2021;13:819. [PMID: 33669217 DOI: 10.3390/cancers13040819] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Cunha CW, O’toole D, Taus NS, Shringi S, Knowles DP, Li H. A Rabbit Model for Sheep-Associated Malignant Catarrhal Fever Research: from Virus Infection to Pathogenesis Studies and Vaccine Development. Curr Clin Micro Rpt 2019;6:148-55. [DOI: 10.1007/s40588-019-00126-3] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
36 Soldan SS, Lieberman PM. Epstein-Barr Virus Infection in the Development of Neurological Disorders. Drug Discov Today Dis Models 2020;32:35-52. [PMID: 33897799 DOI: 10.1016/j.ddmod.2020.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Wang A, Zhang W, Jin M, Zhang J, Li S, Tong F, Zhou Y. Differential expression of EBV proteins LMP1 and BHFR1 in EBV‑associated gastric and nasopharyngeal cancer tissues. Mol Med Rep 2016;13:4151-8. [PMID: 27052804 DOI: 10.3892/mmr.2016.5087] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]